PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells-Reference-Cited by-同舟云学术

PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells

Published:2013-05-15 Issue:6 Volume:123 Page:2604-2615
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

West Erin E.,Jin Hyun-Tak,Rasheed Ata-Ur,Penaloza-MacMaster Pablo,Ha Sang-Jun,Tan Wendy G.,Youngblood Ben,Freeman Gordon J.,Smith Kendall A.,Ahmed Rafi

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference61 articles.

1. Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment

2. Restoring function in exhausted CD8 T cells during chronic viral infection

3. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

4. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends;Experimental & Molecular Medicine;2024-09-02

2. Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints;Science Advances;2024-08-30

3. IL-2 enhances effector function but suppresses follicular localization of CD8+ T cells in chronic infection;2024-08-16

4. IL-2 enhances effector function but suppresses follicular localization of CD8+ T cells in chronic infection;2024-08-16

5. Cytokine-Induced Cell Exhaustion to Mitigate Hyperinflammation;2024-08-12